[go: up one dir, main page]

AU2001251370A1 - Antimicrobial methods and materials - Google Patents

Antimicrobial methods and materials

Info

Publication number
AU2001251370A1
AU2001251370A1 AU2001251370A AU5137001A AU2001251370A1 AU 2001251370 A1 AU2001251370 A1 AU 2001251370A1 AU 2001251370 A AU2001251370 A AU 2001251370A AU 5137001 A AU5137001 A AU 5137001A AU 2001251370 A1 AU2001251370 A1 AU 2001251370A1
Authority
AU
Australia
Prior art keywords
materials
antimicrobial methods
antimicrobial
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001251370A
Inventor
Staffan Arvidson
Che-Shen C. Tomich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Pharmacia and Upjohn Co
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co, Upjohn Co filed Critical Pharmacia and Upjohn Co
Publication of AU2001251370A1 publication Critical patent/AU2001251370A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • G01N33/56938Staphylococcus
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18Testing for antimicrobial activity of a material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/305Assays involving biological materials from specific organisms or of a specific nature from bacteria from Micrococcaceae (F)
    • G01N2333/31Assays involving biological materials from specific organisms or of a specific nature from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001251370A 2000-04-06 2001-04-06 Antimicrobial methods and materials Abandoned AU2001251370A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26632700P 2000-04-06 2000-04-06
US60/266,327 2000-04-06
PCT/US2001/011177 WO2001077365A2 (en) 2000-04-06 2001-04-06 Antimicrobial methods and materials

Publications (1)

Publication Number Publication Date
AU2001251370A1 true AU2001251370A1 (en) 2001-10-23

Family

ID=23014117

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001251370A Abandoned AU2001251370A1 (en) 2000-04-06 2001-04-06 Antimicrobial methods and materials

Country Status (4)

Country Link
US (1) US6764823B2 (en)
EP (1) EP1360315A2 (en)
AU (1) AU2001251370A1 (en)
WO (1) WO2001077365A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6764823B2 (en) 2000-04-06 2004-07-20 Pharmacia & Upjohn Company Antimicrobial methods and materials
JP2005503831A (en) * 2001-09-28 2005-02-10 ファルマシア アンド アップジョン カンパニー リミティド ライアビリティー カンパニー Antimicrobial methods and materials
EP1855717A4 (en) * 2005-02-11 2009-12-23 Ace Biosciences As Surface-located streptococcus pneumoniae polypeptides
AU2008242250B2 (en) 2007-04-19 2014-03-27 Molecular Detection Inc. Methods, compositions and kits for detection and analysis of antibiotic-resistant bacteria
US20110269138A1 (en) * 2008-12-30 2011-11-03 Qiagen Hamburg Gmbh Method for detecting methicillin-resistant staphylococcus aureus (mrsa) strains
WO2020102507A1 (en) * 2018-11-16 2020-05-22 Azitra Inc Auxotrophic strains of staphylococcus bacterium

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8205892D0 (en) 1982-10-18 1982-10-18 Bror Morein IMMUNOGENT MEMBRANE PROTEIN COMPLEX, SET FOR PREPARATION AND USE THEREOF
US5587228A (en) 1985-02-05 1996-12-24 The Boeing Company Microparticle enhanced fibrous ceramics
SE8405493D0 (en) 1984-11-01 1984-11-01 Bror Morein IMMUNOGENT COMPLEX AND KITCHEN FOR PREPARING IT AND USING IT AS IMMUNOSTIMENTING AGENTS
US4877612A (en) 1985-05-20 1989-10-31 Frank M. Berger Immunological adjuvant and process for preparing the same, pharmaceutical compositions, and process
ATE71303T1 (en) 1986-01-14 1992-01-15 Nederlanden Staat PROCESS FOR THE PREPARATION OF IMMUNOLOGICAL COMPLEXES AND PHARMACEUTICAL COMPOSITION CONTAINING THEM.
US4806352A (en) 1986-04-15 1989-02-21 Ribi Immunochem Research Inc. Immunological lipid emulsion adjuvant
CA1340522C (en) 1987-03-10 1999-05-04 Heinz Dobeli Fusion proteins containing neighbouring histidines for improved purification
US5585277A (en) 1993-06-21 1996-12-17 Scriptgen Pharmaceuticals, Inc. Screening method for identifying ligands for target proteins
AU3825995A (en) 1994-10-04 1996-04-26 New York University Blocking expression of virulence factors in s. aureus
WO1999032657A1 (en) * 1997-12-23 1999-07-01 Microcide Pharmaceuticals, Inc. Staphylococcus aureus histidine protein kinase essential genes
US6020121A (en) 1995-09-29 2000-02-01 Microcide Pharmaceuticals, Inc. Inhibitors of regulatory pathways
US5783397A (en) 1995-12-11 1998-07-21 Northeastern University Screening natural samples for new therapeutic compounds using capillary electrophoresis
US6737248B2 (en) * 1996-01-05 2004-05-18 Human Genome Sciences, Inc. Staphylococcus aureus polynucleotides and sequences
JP2000509246A (en) * 1996-02-20 2000-07-25 スミスクライン・ビーチャム・コーポレイション New compound
EP1002090A2 (en) * 1997-05-06 2000-05-24 Human Genome Sciences, Inc. $i(ENTEROCOCCUS FAECALIS) POLYNUCLEOTIDES AND POLYPEPTIDES
US6455323B1 (en) 1997-07-03 2002-09-24 Pharmacia & Upjohn Company Anti-bacterial methods and materials
US6111074A (en) 1998-02-26 2000-08-29 Smithkline Beecham Corporation PyrH of Streptococcus pneumoniae
JP2002512777A (en) 1998-04-27 2002-05-08 スミスクライン・ビーチャム・コーポレイション New pyrH
EP1109911A4 (en) 1998-09-01 2005-04-27 Human Genome Sciences Inc Staphylococcus aureus genes and polypeptides
ES2353268T3 (en) 1999-07-02 2011-02-28 Morphosys Ag GENERATION OF SPECIFIC UNION ELEMENTS THAT JOIN (POLI) PEPTIDES CODIFIED BY FRAGMENTS OF GENOMIC DNA OR EST.
CA2388734A1 (en) 1999-09-01 2001-03-08 Human Genome Sciences, Inc. 37 staphylococcus aureus genes and polypeptides
AU1478301A (en) 1999-11-09 2001-06-06 Glaxo Group Limited Staphylococcus epidermidis nucleic acids and proteins
EP1248813A2 (en) 2000-01-04 2002-10-16 Avi Biopharma, Inc. Antisense antibacterial cell division composition and method
US6764823B2 (en) 2000-04-06 2004-07-20 Pharmacia & Upjohn Company Antimicrobial methods and materials

Also Published As

Publication number Publication date
WO2001077365A2 (en) 2001-10-18
WO2001077365A3 (en) 2003-08-21
US6764823B2 (en) 2004-07-20
EP1360315A2 (en) 2003-11-12
US20020168697A1 (en) 2002-11-14

Similar Documents

Publication Publication Date Title
EP1621217B8 (en) Antimicrobial powder and material
AU2002235128A1 (en) Expression miniarrays and uses thereof
AU2001281758A1 (en) Biocompatible materials
AU2001287299A1 (en) Benzoylpyrazols and their use as herbicides
AU2001250875A1 (en) Anti-microbial and immunostimulating composition
AU2001280599A1 (en) Compounds and methods
AU2002243246A1 (en) Cddo-compounds and combination therapies thereof
AU2001253418A1 (en) Compounds and methods
AU2001277526A1 (en) Substituted benzo-nitro-heterocycles and use thereof as herbicides
AU2001240637A1 (en) Novel imidazotriazinones and the use thereof
AU2002219135A1 (en) Substituted 2-anilino-benzimidazoles and the use thereof as NHE-inhibitors
AU2001264258A1 (en) Nonwoven-fabric laminate and use thereof
AU2002211717A1 (en) Stresscopins and their uses
AU2001239773A1 (en) Baroplastic materials
AU2001243394A1 (en) Compounds and methods
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU7458201A (en) Laminate and use thereof
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AUPQ872300A0 (en) Compounds and methods
AU5464901A (en) Dichloropyridyl- and dichloroisothiazolyl-thiocarboxamides and their use as microbicides
AU2001278951A1 (en) Compounds and methods
AU2001237025A1 (en) Antimicrobial composition and articles
AU2000231564A1 (en) Phosphororganic compounds and the use thereof
AU2001251370A1 (en) Antimicrobial methods and materials
AU2001267589A1 (en) Cycloalkyl - or cycloalkylmethyl-substituted 6-phenylphenanthridines